baber/WOPTO huggingface dataset:
Patent BR-PI1001696-B1 (BR)
Title: sinalizador de frenagem
Inventor: FLAVIANO LOPES FERREIRA
IPC: B60Q1/26
Filed: 2010-05-11
Abstract: sinalizador de frenagem o sinalizacior de frenagem em veículos automotores em geral, a ser instalado em qualquer parte da traseira de todo e qualquer veículo automotor, proporciona que o veículo que trafegue atrás do condutor da frente, tenha uma informação segura e em tempo real do grau de freriagem ou porcentagem (%) que o veículo da frente implementou, quando acionar o freio para que o veículo que segue atrás possa fazer o mesmo, evitando-se assim colisões na traseira. as luzes vermelhas hoje instaladas na parte traseira dos veículos automotores em geral, não indicam a intensidade da frenagem do motorista, mas apenas que houve o acionamento dos freios, sendo que o sinalizador de frenagem indica de forma segura e simultânea o grau de frenagem que o veículo que segue imediatamente à sua frente implementou, proporcionando que o veículo automotor que venha imediatamente atrás tome a mesma medida evitando-se colisões.
Patent BR-PI1004573-B1 (BR)
Title: Substituição livre de ferramentas de curvas de orientação de garrafas
Inventor: WERNER SÜTHER
IPC: B65G21/20
Filed: 2010-03-26
Abstract: substituição livre de ferramentas de curvas de orientação de garrafas a presente invenção refere-se a um elemento de orientação que compreende elementos de orientação parcial ( 2, 3) que podem esr interconectados por meio de pelo menos um elemento de conexão (4), a fim de fornecer um elemento de orientação que pode ser substituido de forma muito simples e com economia de tempo, particularmente uma placa estrela substituivel. a presente invenção propõe que pelo menos um elemento de conexão (4) compreenda um primeiro elemento de conexão parcial ( 5) e um segundo elemento de conexão parcial ( 6) f em c:,ue um dos dois elementos de conexão parcial ( 5, 6) compreende um receptáculo travável ( 7 ) f no qual o lado de inserção ( 8) do outro elemento de conexão parcial ( 5, 6) correspondente ao receptáculo ( 7) pode ser inserido, de tal f o rma que o elemento de conexão parcial ( 5 f 6) seja retido de forma fixa na posição no outro elemento de conexã o parcial ( 5, 6) em forma de encaixe forçado quando o re c eptáculo travável (7) .estiver travado.
Patent BR-PI1013523-B1 (BR)
Title: estator de máquina elétrica giratória
Inventor: BRAHIM AMMAR
IPC: H02K1/18
Filed: 2010-03-23
Abstract: estator de máquina elétrica giratória a presente invenção refere-se a um estator (100) de uma máquina elétrica giratória, comportando uma carcaça (101) que comporta um envoltório externo e duas placas de extremidades (111, 112), uma estrutura magnética do estator (103) formada por um empilhamento de chapas magnéticas mantido em uma armazenagem formada por faces (137, 138) ligadas por barras (133); esse estator (100) sendo caracterizado pelo fato de essa carcaça (101) comportar placas intermediárias (117) de forma semicircular que forma berço apto a suportar essa estrutura magnética do estator (103), essas faces (137, 138) serem de forma semicircular adaptada para assumir a foram semicircular dessas placas intermediárias (117) dessa carcaça (101), quando essa estrutura magnética do estator (103) é colocada nessa carcaça (101), essas faces (137, 138) comportando uma parte superior (144) que apresenta duas bordas paralelas verticais apta ser solidarizada com esse envoltório externo (110) dessa carcaça (101).
Patent BR-PI1105386-B1 (BR)
Title: aeronave e sistema de anti-colisão
Inventor: CRAIG ALAN HOOVER
IPC: G01S13/933
Filed: 2011-12-20
Abstract: SISTEMA DE ANTI-COLISÃO E AERONAVE. Trata-se de um sistema de anti-colisão baseado em trajetória (168) para o uso em uma aeronave (100) que utiliza construções em 4-D (166, 192), como trajetórias em 4-D ou polítopos em 4-D, para manter o afastamento de outra aeronave (118) e/ou para evitar colisões com outra aeronave (118). Em determinadas realizações, o sistema de anti-colisão baseado em trajetória (168) utiliza trajetórias em 4-D fornecidas a partir de uma fonte externa e/ou trajetórias em 4-D estimadas com base em um variedade de fontes de dados durante a operação.
Patent EA-005095-B1 (EA)
Title: Method for preparing antitumor formulation "cinnaborin"
Inventor: PLENINA LUDMILA VASILIEVNA
IPC: A61K31/715
Filed: 2000-02-07
Abstract: A method for the preparation of an antitumor formulation "Cinnaborin" by submerged cultivation of a myceluim of a species of Basidomycetes in a nutrient medium, characterized in that the submerged cultivation carried out from a mycelium of a species Picnoporus cinnabarius during 96 hours in a nutrient medium, comprising a free hop wort with saccharide content up to 14 degree B, water in ratio 1:3 and agar-agar, with subsequent isolation and purification of a final product, isolation of polysaccharides from dried filtrate of the culture broth, the polysaccharides are isolated from the dried filtrate of the culture broth by 7% solution of sodium hydroxide with a weight ratio 1:10 at 64-67 degree C with subsequent cooling and neutralization hydrolysate 4N with HCl to pH 6.9-7.1 the purification is carried out by ultrafiltration and triple dialysis by water and subsequent precipitation by 96% of ethanol.
Patent EA-011384-B1 (EA)
Title: Method for the treatment of inflammatory disorder
Inventor: DE FOUGEROLLES ANTONIN
IPC: A61P/
Filed: 2000-06-01
Abstract: A method for the treatment of inflammatory disorders is disclosed, comprising administering to the subject suffering from inflammatory disorder an antibody or fragment thereof capable of binding an epitope of VLA-1 wherein the epitope comprises amino acid residues 91-96 of Figure 15 (SEQ ID NO:8).
Patent EA-009036-B1 (EA)
Title: New crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid
Inventor: RICHTER JINDRICH
IPC: C07F9/38
Filed: 2003-10-21
Abstract: A crystalline, hydrated form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid contains from 6.4 up to 22 weight % of sodium, based on the anhydrous substance, and 15 up to 23 weight % of crystalline water if the sodium content is lower than 7.5 weight %, or 4.5 up to 18 weight % if the sodium content is higher than 7.5 weight %.
Patent EA-009468-B1 (EA)
Title: Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
Inventor: ABOUABDELLAH AHMED
IPC: A61K31/436
Filed: 2004-05-06
Abstract: The invention relates to a compound having general formula (I),wherein: A = N or CR; R= H, F, OH, CN, CF, C-alkyl, Calcoxy; n = 2 or 3 and m = 2 when A = N; n = 1, 2 or 3 and m = 1 or 2 when A = CR; B = covalent bond or Calkylene; R= optionally-substituted heteroaryl; R= CHR4CONHR; R= H or Calkyl; R= H, Calkyl, Ccycloalkyl, Ccycloalkyl- Calkylene; the base, the acid addition salt, the hydrate or the solvate thereof. The invention also relates to the application thereof in therapeutics.
Patent EA-007824-B1 (EA)
Title: Method for fire refining of metals in the thermodynamically equilibrium system of a dip-gas medium
Inventor: MARTEMIANOV YURI VASILIEVICH
IPC: C22B9/05
Filed: 2004-10-28
Abstract: Generally, fire refining of metals is carried out by blowing through a liquid melt thick layer and significantly rarely by mixing a melt stream with a gas. Said methods are low-productive and do not ensure rapid gas access to each melt drop.The inventive method for fire refining of metals in a thermodynamically equilibrium system consists in supplying a thin and wide metal layer to a special chamber provided with an inclined bottom and a receiver. Gases are supplied to the chamber through tuyeres embodied in the front wall thereof and through the bottom and form, together with the supplied melt, a drip-gas fog which is thermodynamically equilibrium by sufficiently heating gases and metals to temperatures which ensure a metal flowing temperature excess in a drip-gas mixture for a whole oxidizing-reducing period.Said method ensures a high productivity by rapid gas access to each melt drop and reduces materials consumption of a device, as well as improves the treatment quality. In particular, it is possible to obtain copper of M 1 grade using a method of electrolytic refining.The proposed method is applicable to the treatment of copper, aluminium, nickel, lead, tin, iron and steel alloys and to other metals to which fire refining method can be applied.
Patent EA-008301-B1 (EA)
Title: Roll forming device
Inventor: SHAPLYKO VALERIJ IVANOVICH
IPC: A01F15/07
Filed: 2003-11-17
Abstract: The inventive roll forming device comprises a raw material loading unit, a permanent volume limiting unit provided with elements for forming an internal cylindrical surface, end stops and with an originally designed forming mechanism embodied in the form of parallel endless chains and forming elements arranged therebetween, wherein said forming elements are combined with elements for forming the internal cylindrical surface.In the second embodiment, said roll forming device also comprises means for rotationally moving the end stops, which is connected to chain driving means in such a way that it is possible to co-ordinate a motion therewith.
Patent EA-008355-B1 (EA)
Title: Transferring element of a pusher mechanism of a glass forming machine
Inventor: COUFAL MARTIN
IPC: C03B9/453
Filed: 2005-03-29
Abstract: A transferring element of a pusher mechanism of a glass forming machine comprising at least one jaw (20) with a base (12) and an arm (13) while a nozzle (23) for feeding of pressurized air from a central source (31) leads to the area of the jaw (20). The nozzle (23) is arranged in the lower part of the corner between the base (12) and the arm (13) and is directed upwards, parallel to the arm (13).
Patent EA-009891-B1 (EA)
Title: Method and apparatus for the purification of ground water
Inventor: HALLBERG ROLF O
IPC: C02F1/64
Filed: 2004-08-06
Abstract: The present invention relates to a method for decreasing the contents of metals, metalloids, nitrate and nitrite, respectively, in raw water flowing through a basin (1), whereby water containing either oxygen, oxygen-releasing substances, metabolic reactions of naturally occurring micro-organisms or containing denitrification organisms and/or substrates therefore is intermittently introduced to the basin (1) through a number of satellite wells (2) arranged around at least one extraction well(3) for purified water. Water containing oxygen and/or oxygen-releasing substances or metabolic reactions of naturally occurring micro-organisms or denitrification organisms and/or substrates therefore is homogeneously distributed vertically in said basin (1), whereby the water to be purified is fed into the basin by horizontally arranged feeding pipes (5) and that the extraction of purified water from said at least extraction well (3) is such that a substantially negative pressure is created around said at least one extraction well (3). The invention relates also to an apparatus for carrying out the method and to a satellite well to be used in the apparatus.
Patent EA-014559-B1 (EA)
Title: A method for the preparation of (s)-n-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine)
Inventor: RIDVAN LUDEK
IPC: C07D333/20
Filed: 2006-12-22
Abstract: A method of preparation of (S)-N-methyl-3-(1-naphthyloxy)-3-(2-mienyl)propylamine of Formula(I) and its pharmaceutically acceptable salts, comprising a) reaction of (RS)-N,N-dimethyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine of formula (III) with optically active D-tartaric acid or an acid salt derived from D-tartaric acid forming a mixture of diastereoisomeric salts of N,N-dimethyl-3-(l-naphthyloxy)- 3-(2-thienyl)propylamine and D-tartaric acid (2:1), b) isolation of the salt (S)-N,N-dimethyl-3-(naphthyloxy)-3-(2-thienyl)propylamine/D-tartrate (2:1) from the mixture of diastereoisomeric salts in an organic solvent, water or a mixture thereof and release of (S)-N,N-dimethyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine of formula (S)-(III) by action of an inorganic or organic base, c) demethylation of (S)-N,N-dimethyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine by action of an alkylchloroformate of formula ClCOOR (R = C-Calkyl, or C-Caryl or alkylaryl), especially phenyl, ethyl or methyl chloroformate, and d) hydrolytic release of the duloxetine base of formula (I) and optionally conversion of the base to a salt with the respective acid, or salt of a weak base, wherein one uses, as the optically active substance in step (a), D-tartaric acid in the molar ratio 1:2 relative to the substance of formula (III), or an alkali metal acid D-tartrate or ammonium tartrate, or alternatively alkylammonium tartrate of formula (IV) in the molar ratio 1:1 relative to the substance of formula (III).
Patent EA-018510-B1 (EA)
Title: Physiotherapy device
Inventor: YAMAEV ANATOLIJ MIKHAILOVICH
IPC: A61H9/00
Filed: 2009-10-14
Abstract: The present invention relates to the medical equipment and is designed for a number of skin, nervous, cardiovascular, muscular, dentition systems diseases physiotherapy (dermatology, neurology, cardiology, traumatology, surgery, dentistry) with the use of the medicines in combination with local dosed vacuum and punctual darsonvalization. The invention provides a physiotherapy device, which comprises a tubular darsonvalization electrode, with a tip located on its one end and a radio-frequency voltage source-connected holder located on the other end. The electrode tip comprising an additional operating element, designed as two concentric tubular elements, mounted with a gap with respect to each other and hermetically connected to each other on the side of the electrode tip by a division wall, installed in a longitudinal centre-line plane, forming an internal cavity and an outer annular cavity, which are hermetically separated from one another and open on the side opposite to the electrode holder, the inner cavity being hermetically connected with the electrode tip and designed to be connected through a channel for the medicine delivery, hermetically connected with the internal cavity, with a medicine source and the outer annular cavity being designed to be connected through a channel for vacuum delivery, hermetically connected with it, with a vacuum source. The device provides an opportunity for enhancement of the complex and combined use of high-frequency alternating impulse currents of high-voltage and weak-force (d'Arsonval currents), local dosed vacuum and medicines, allowing for increasing therapeutic intervention efficiency.
Patent EA-027285-B1 (EA)
Title: Dental implant
Inventor: SANDERS DANIEL
IPC: A61C8/00
Filed: 2010-02-02
Abstract: A dental implant is provided for the insertion of improved anatomically corrected modular design anterior and posterior dental implants, the implant including a root component and a head/abutment component, wherein the root component is inserted into the jawbone using precision surgical guide tools in combination with self-limiting surgical templates and a precision adjustable clamping device.
Patent EA-019726-B1 (EA)
Title: Iron with external water reservoir
Inventor: TAHINCIOGLU BESIM
IPC: D06F75/12
Filed: 2010-04-22
Abstract: The present invention proposes a domestic appliance and specifically an ironing appliance having an external water reservoir (12) connected to the appliance through a feeding tube. Water conveyed to the ironing unit (11) is directly subjected to an independently heated inner plate (18) where steam is directly produced and conveyed to the soleplate (17) whose temperature being independently adjusted. The independently heated inner plate comprises a pair of covers (22, 23) set one above the other. The first cover (22) receives water through its openings (24) and channels (28) and the second cover (23) lying just below the first one to define an inner space (31) allows conveyance of the water to the steam producing plate. The steam then reaches the soleplate to be applied to the cloth item being ironed.
Patent EA-021857-B1 (EA)
Title: Simultaneous phase and amplitude control using triple stub topology and its implementation using rf mems technology
Inventor: UNLU MEHMET
IPC: H01P1/22
Filed: 2009-09-15
Abstract: This invention relates to techniques for controlling the amplitude and the insertion phase of an input signal in RF applications. More particularly, this invention relates to phase shifters, vector modulators, and attenuators employing both semiconductor and RF microelectromechanical systems (MEMS) technologies.
Patent EA-023721-B1 (EA)
Title: Aqueous slurry for battery electrodes
Inventor: BUQA HILMI
IPC: H01M4/04
Filed: 2012-06-29
Abstract: The present invention relates to a slurry or paste for the manufacture of electrodes for secondary batteries such as lithium ion containing electrochemical cells. The slurry comprises a water based binder with CMC, SBR and PVDF as binder materials.
Patent EA-032297-B1 (EA)
Title: Pharmaceutical composition for treatment of endometriosis
Inventor: ILYICHEV ALEXANDER VLADIMIROVICH
IPC: A61K35/54
Filed: 2015-02-26
Abstract: The invention relates to a pharmaceutical composition based on the raw material of animal origin for treatment of endometriosis. The pharmaceutical composition includes serum albumin and protein of TGF-β family having immunospecificity of inhibin βA both isolated from the cattle follicular fluid and also salt NaCl. The technical result of the invention consists in the enhanced efficiency of treatment of endometriosis due to considerable reduction or complete absence of recurrences after a therapy course, absence of significant side effects, normalization of the hormone status.
Patent EA-035174-B1 (EA)
Title: 2-aminopyrimidine derivatives as modulators of toll-like receptors tlr7 and/or tlr8
Inventor: MC GOWAN DAVID CRAIG
IPC: A61P31/12
Filed: 2014-02-20
Abstract: The present invention relates to 2-aminopyrimidine derivatives of formula (I), pharmaceutical compositions and their use as modulators of toll-like receptors TLR7 and/or TLR8.
Patent EA-030786-B1 (EA)
Title: Method for surgery treatment of stomach atony
Inventor: GYRKHLAROVA AJTEN SABIR KYZY
IPC: A61B17/00
Filed: 2016-07-08
Abstract: The invention relates to medicine, particularly surgery, and may be applied to surgical gastroenterology, particularly to treatment and prevention of post-resection and post-vagotomy stomach atonic conditions. Atonic conditions are often combined with gastroptosis, whereas constitutional or acquired asthenia may cause either gastroptosis, or atony, or hypotony of stomach. Task of the invention consists in surgical treatment of atony concomitant with gastroptosis, but without damage to, or removal of the sphincter, including complications caused by pylorus conserving reactions, through normalization of passage of stomach contents to duodenum and prevention of duodenogastric reflux and damping syndrome. The task stated is achieved in the method for surgery treatment of stomach atony concomitant with gastroptosis, according to the invention, wherein a loop of small intestine is sutured to the stomach, such that bowel peristalsis passed to stomach muscles; then an anastomosis is formed between stomach and small intestine for accelerated food mass evacuation from stomach to small intestine, preceded by distal end closure, which distal end is lead to esophagogastric transition zone, wherein distal part of small intestine is arranged along lesser curvature of stomach, and the distal end is fixed in this position using serous-to-serous suture, whereupon a side anastomosis between small intestine proximal end and side surface of intestine distal part is performed; at that, incision of small intestine is made at 20 to 30 cm distance from Treitz ligament, intestine distal part is fixed in a position wherein the mesentery is arranged laterally, the free edge being medial, and mesenterial vessels and lesser omentum vessels are sutured together during fixation of intestine distal part.
Patent EA-032010-B1 (EA)
Inventor: RUDENSKAYA NATALYA ALEXANDROVNA
IPC: C23C4/12
Filed: 2016-09-22
Abstract: Изобретение относится к области нанесения газотермических покрытий, более конкретно - к способам нанесения плазменных покрытий на детали, эксплуатируемые в условиях износа, высоких температур, коррозионных сред и ударных нагрузок. Задача предлагаемого технического решения состоит в создании покрытия, упрочненного высокобарными фазами стишовита и характеризующегося высокой плотностью в сочетании с высокой микротвердостью составляющих покрытие фаз. Поставленная задача достигается тем, что процесс ведут с использованием как дозвукового, так и сверхзвукового плазменного потоков и керамических микрокомпозитов с оболочкой из SiOпри соотношении компонентов оболочки и ядра 30-50 и 50-70 соответственно, при этом дисперсность частиц SiOсоставляет менее 20 мкм.
Patent EA-031431-B1 (EA)
Title: Pneumatic compact vacuum toilet
Inventor: OREMEK PETER
IPC: E03F1/00
Filed: 2015-04-09
Abstract: The invention relates to a pneumatic compact vacuum toilet (10) comprising a toilet bowl (1) with an outlet channel (1a) which opens into an intermediate tank (3), wherein the intermediate tank (3) has a wastewater channel (3a) through which wastewater can be discharged gravitationally from the intermediate tank (3), and wherein the outlet channel (1a) has an outlet valve (2) which is arranged and designed to close the outlet channel (1a) in a first outlet valve position and to open it in a second outlet valve position, and the wastewater channel (3a) has a wastewater valve (5) which is arranged and designed to open the wastewater channel (3a) in a first wastewater valve position and to close it in a second wastewater valve position, and wherein the outlet valve (2) and the wastewater valve (5) are designed as pneumatic shut-off valves.
Patent EA-037749-B1 (EA)
Title: INTERFERON 2b VARIANTS
Inventor: BEHRENS COLLETTE
IPC: C12N15/21
Filed: 2015-10-23
Abstract: The invention relates to a fusion polypeptide comprising a first domain and a second domain, wherein the first domain comprises a polypeptide ligand which binds to a cell surface-associated antigen and the second domain comprises aglycosylated interferon 2b (IFN2b) having a sequence of SEQ ID NO: 1 or SEQ ID NO: 2. The aglycosylated IFN2b further comprises one or more amino acid substitutions or deletions which attenuate the activity of the aglycosylated IFN2b.
Patent EA-033992-B1 (EA)
Title: Compositions containing ibrutinib
Inventor: GOLE DILIP
IPC: A61K47/38
Filed: 2016-04-06
Abstract: Discussed herein are pharmaceutical compositions containing Ibrutinib and processes for preparing them. The compositions may be utilized in the treatment of a variety of conditions including, without limitation, B-cell proliferative disorders such as non-Hodgkin lymphoma (diffuse large B cell lymphoma, follicular lymphoma, mantle cell lymphoma or burkitt lymphoma), Waldenstrom macroglobulinemia, plasma cell myeloma, chronic lymphocytic leukemia, lymphoma, or leukemia. These compositions are designed for oral ingestion. The compositions are contained within a capsule such as a standard or sprinkle or in a liquid formulation such as a suspension. In one embodiment, the pharmaceutical composition contains Ibrutinib, a salt, prodrug, or metabolite thereof, microcrystalline cellulose, croscamieliose sodium, sodium lauryl sulfate, and magnesium stearate. In another embodiment, the pharmaceutical composition contains Ibrutinib, a salt, prodrug, or metabolite thereof, microcrystalline cellulose, carboxymethylcellulose sodium, hydroxypropylmethylcellulose, citric acid monohydrate, disodium hydrogen phosphate, sucralose, sodium methyl parahydroxybenzoate, sodium ethyl parahydroxybenzoate, concentrated hydrochloric acid, sodium hydroxide, and water.